MIRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MIRA Pharmaceuticals Inc is not a strong buy at this moment for a beginner investor with a long-term strategy. The technical indicators are neutral, there are no significant trading trends, no positive news catalysts, and the financial performance shows significant losses. Additionally, Intellectia Proprietary Trading Signals do not indicate a buy opportunity today.
The MACD is slightly positive but contracting, RSI is neutral at 33.924, and moving averages are converging, indicating no clear trend. The stock is trading below the pivot level of 1.222, with key support at 1.131 and resistance at 1.314.
NULL identified. There are no recent news or significant trading trends.
The stock has a high probability of declining in the short term (-0.72% in the next day, -8.55% in the next week, -3.97% in the next month). Financial performance is weak, with significant net income losses and negative EPS.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income loss of -22,694,494 (up 1010.37% YoY), and an EPS of -1.18 (up 742.86% YoY). These figures indicate a company struggling financially.
No analyst ratings or price target changes available.
